Financial Ratios Marubeni Corporation
Stocks
8002
JP3877600001
Diversified Industrial Goods Wholesale
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,879.00 JPY | -0.91% |
|
-1.69% | +12.08% |
| 06-17 | Japanese Shares Recoup Early Losses as Investors Await US Fed Policy, Middle East Developments | MT |
| 06-17 | Marubeni Acquires US Gas Developer EagleRidge | MT |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.47 | 2.96 | 2.42 | 2.45 | 1.63 | |||||
Return on Total Capital | 3.9 | 4.64 | 3.54 | 3.47 | 2.43 | |||||
Return On Equity % | 20.49 | 20.78 | 14.75 | 14.05 | 13.5 | |||||
Return on Common Equity | 20.77 | 21.11 | 14.85 | 14.19 | 13.61 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 10.71 | 11.91 | 15.4 | 15.78 | 14.31 | |||||
SG&A Margin | 7.13 | 7.67 | 10.77 | 11.08 | 11.05 | |||||
EBITDA Margin % | 4.51 | 5.21 | 5.92 | 6.07 | 5.63 | |||||
EBITA Margin % | 3.64 | 4.3 | 4.69 | 4.75 | 3.11 | |||||
EBIT Margin % | 3.53 | 4.18 | 4.51 | 4.56 | 3.11 | |||||
Income From Continuing Operations Margin % | 5.11 | 6.02 | 6.66 | 6.61 | 6.76 | |||||
Net Income Margin % | 4.99 | 5.91 | 6.5 | 6.46 | 6.58 | |||||
Net Avail. For Common Margin % | 4.95 | 5.88 | 6.49 | 6.46 | 6.58 | |||||
Normalized Net Income Margin | 3.71 | 4.04 | 4.88 | 4.74 | 4.08 | |||||
Levered Free Cash Flow Margin | -1.63 | 3.6 | -1.17 | 1.89 | 2.01 | |||||
Unlevered Free Cash Flow Margin | -1.47 | 3.99 | -0.54 | 2.54 | 2.61 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.12 | 1.13 | 0.86 | 0.86 | 0.84 | |||||
Fixed Assets Turnover | 8.7 | 9.66 | 7.15 | 7.06 | 7.28 | |||||
Receivables Turnover (Average Receivables) | 7.07 | 6.82 | 5.02 | 5.08 | 5.35 | |||||
Inventory Turnover (Average Inventory) | 6.3 | 6.29 | 5.29 | 5.63 | 5.77 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.21 | 1.34 | 1.39 | 1.42 | 1.37 | |||||
Quick Ratio | 0.52 | 0.7 | 0.72 | 0.74 | 0.65 | |||||
Operating Cash Flow to Current Liabilities | 0.08 | 0.22 | 0.16 | 0.21 | 0.16 | |||||
Days Sales Outstanding (Average Receivables) | 51.59 | 53.56 | 72.9 | 71.92 | 68.2 | |||||
Days Outstanding Inventory (Average Inventory) | 57.94 | 58 | 69.14 | 64.8 | 63.21 | |||||
Average Days Payable Outstanding | 60.75 | 65 | 79.02 | 74.45 | 69.85 | |||||
Cash Conversion Cycle (Average Days) | 48.78 | 46.56 | 63.01 | 62.27 | 61.56 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 114.5 | 78.67 | 75.16 | 73.68 | 53.39 | |||||
Total Debt / Total Capital | 53.38 | 44.03 | 42.91 | 42.42 | 34.81 | |||||
LT Debt/Equity | 80.58 | 60.38 | 59.09 | 58.19 | 42.94 | |||||
Long-Term Debt / Total Capital | 37.56 | 33.8 | 33.74 | 33.51 | 27.99 | |||||
Total Liabilities / Total Assets | 71.68 | 62.51 | 60.07 | 59.05 | 57.14 | |||||
EBIT / Interest Expense | 13.75 | 6.77 | 4.51 | 4.42 | 3.23 | |||||
EBITDA / Interest Expense | 19.93 | 9.38 | 6.84 | 6.79 | 5.86 | |||||
(EBITDA - Capex) / Interest Expense | 15.27 | 7.54 | 4.73 | 4.58 | 3.93 | |||||
Total Debt / EBITDA | 6.15 | 4.41 | 5.39 | 5.09 | 5.17 | |||||
Net Debt / EBITDA | 4.82 | 3.26 | 4.37 | 4.04 | 3.99 | |||||
Total Debt / (EBITDA - Capex) | 8.03 | 5.48 | 7.8 | 7.54 | 7.72 | |||||
Net Debt / (EBITDA - Capex) | 6.3 | 4.05 | 6.33 | 5.99 | 5.95 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 34.37 | 8.01 | -21.11 | 7.44 | 6.11 | |||||
Gross Profit, 1 Yr. Growth % | 30.85 | 20.16 | 2.02 | 10.1 | 3.15 | |||||
EBITDA, 1 Yr. Growth % | 53.71 | 24.78 | -10.29 | 10.18 | -1.25 | |||||
EBITA, 1 Yr. Growth % | 79.05 | 27.71 | -14.02 | 8.79 | -5.74 | |||||
EBIT, 1 Yr. Growth % | 84.89 | 28 | -14.82 | 8.56 | -5.74 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 88.31 | 27.1 | -12.71 | 6.73 | 8.57 | |||||
Net Income, 1 Yr. Growth % | 90.06 | 27.97 | -13.18 | 6.69 | 8.13 | |||||
Normalized Net Income, 1 Yr. Growth % | 86.91 | 17.57 | -4.76 | 4.4 | -8.71 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 92.16 | 30.17 | -11.52 | 8.33 | 9.12 | |||||
Accounts Receivable, 1 Yr. Growth % | 27.21 | -0.57 | 15.99 | -2.09 | 3.38 | |||||
Inventory, 1 Yr. Growth % | 44.64 | -18.97 | 1.8 | 0.14 | 7.84 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.7 | -0.74 | 14.12 | 4.06 | 1.72 | |||||
Total Assets, 1 Yr. Growth % | 19.03 | -3.66 | 12.2 | 3.12 | 14.45 | |||||
Tangible Book Value, 1 Yr. Growth % | 28.75 | 31.86 | 19.35 | 3.59 | 19.45 | |||||
Common Equity, 1 Yr. Growth % | 23.55 | 28.35 | 20.22 | 4.9 | 20.24 | |||||
Cash From Operations, 1 Yr. Growth % | -21.44 | 94.39 | -27.03 | 35.14 | -10.46 | |||||
Capital Expenditures, 1 Yr. Growth % | -17.96 | 2.41 | 47.1 | 15.77 | -13.55 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -177.79 | -338.57 | -125.58 | -274.01 | 1.89 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -164.91 | -393.01 | -110.72 | -602.76 | 1.19 | |||||
Dividend Per Share, 1 Yr. Growth % | 87.88 | 25.81 | 8.97 | 11.76 | 13.16 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.63 | 20.47 | -7.69 | -7.93 | 6.77 | |||||
Gross Profit, 2 Yr. CAGR % | 16.03 | 25.39 | 10.72 | 5.98 | 2.91 | |||||
EBITDA, 2 Yr. CAGR % | 31.67 | 38.49 | 5.8 | -0.58 | 4.14 | |||||
EBITA, 2 Yr. CAGR % | 57.23 | 51.22 | 4.79 | -3.28 | -13.1 | |||||
EBIT, 2 Yr. CAGR % | 62.42 | 53.84 | 4.42 | -3.84 | -11.44 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 51.23 | 54.7 | 5.33 | -3.48 | 7.65 | |||||
Net Income, 2 Yr. CAGR % | 46.59 | 55.95 | 5.4 | -3.76 | 7.41 | |||||
Normalized Net Income, 2 Yr. CAGR % | 223.56 | 48.24 | 5.82 | -0.29 | -2.38 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 44.55 | 58.16 | 7.32 | -2.09 | 8.73 | |||||
Accounts Receivable, 2 Yr. CAGR % | 12.81 | 12.47 | 7.39 | 6.57 | 0.61 | |||||
Inventory, 2 Yr. CAGR % | 29.44 | 8.26 | -9.18 | 0.97 | 3.92 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.86 | -2.74 | 6.43 | 8.98 | 2.89 | |||||
Total Assets, 2 Yr. CAGR % | 14.29 | 7.09 | 3.97 | 7.56 | 8.64 | |||||
Tangible Book Value, 2 Yr. CAGR % | 26.23 | 30.29 | 25.45 | 11.19 | 11.24 | |||||
Common Equity, 2 Yr. CAGR % | 21.64 | 25.93 | 24.22 | 12.3 | 12.31 | |||||
Cash From Operations, 2 Yr. CAGR % | -2.33 | 23.57 | 19.1 | -0.69 | 10 | |||||
Capital Expenditures, 2 Yr. CAGR % | -3.74 | -8.34 | 22.74 | 30.5 | 0.04 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 31.25 | 36.23 | -21.87 | -33.28 | 40 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 6.45 | 37.91 | -43.94 | -26.57 | 134.27 | |||||
Dividend Per Share, 2 Yr. CAGR % | 33.1 | 53.74 | 17.09 | 10.36 | 12.46 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.76 | 10.41 | 4.62 | -2.9 | -3.47 | |||||
Gross Profit, 3 Yr. CAGR % | 7.68 | 17.39 | 17.06 | 10.51 | 2.61 | |||||
EBITDA, 3 Yr. CAGR % | 11.04 | 29.33 | 19.83 | 7.24 | -0.91 | |||||
EBITA, 3 Yr. CAGR % | 19.34 | 46.7 | 25.28 | 6.11 | -13.4 | |||||
EBIT, 3 Yr. CAGR % | 20.16 | 50.02 | 26.32 | 5.78 | -12.58 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 22.04 | 42.71 | 27.84 | 5.79 | 0.38 | |||||
Net Income, 3 Yr. CAGR % | 22.49 | 40.1 | 28.29 | 5.83 | 0.05 | |||||
Normalized Net Income, 3 Yr. CAGR % | 26.71 | 130.89 | 27.91 | 5.34 | -3.18 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 22.89 | 39.59 | 30.32 | 7.66 | 1.51 | |||||
Accounts Receivable, 3 Yr. CAGR % | 1.42 | 8.16 | 13.63 | 4.13 | 5.5 | |||||
Inventory, 3 Yr. CAGR % | 16.64 | 10.73 | 6.06 | -6.17 | 3.21 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 1.02 | 1.64 | 2.58 | 5.64 | 6.5 | |||||
Total Assets, 3 Yr. CAGR % | 6.63 | 7.96 | 8.76 | 3.68 | 9.81 | |||||
Tangible Book Value, 3 Yr. CAGR % | 6.94 | 28.08 | 26.54 | 17.69 | 13.88 | |||||
Common Equity, 3 Yr. CAGR % | 4.27 | 23.83 | 23.99 | 17.41 | 14.89 | |||||
Cash From Operations, 3 Yr. CAGR % | 3.07 | 22.86 | 3.67 | 24.22 | -4.06 | |||||
Capital Expenditures, 3 Yr. CAGR % | 2.98 | -1.73 | 7.32 | 20.37 | 13.76 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 32.23 | 60.19 | -21.98 | 2.03 | -20.55 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 59.66 | 49.18 | -41.13 | 16.47 | -16.19 | |||||
Dividend Per Share, 3 Yr. CAGR % | 22.17 | 30.62 | 37.08 | 15.29 | 11.29 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.6 | 4.04 | -0.41 | 2.67 | 5.47 | |||||
Gross Profit, 5 Yr. CAGR % | 8.21 | 10.08 | 8.88 | 12.69 | 11.18 | |||||
EBITDA, 5 Yr. CAGR % | 14.05 | 15.5 | 8.91 | 16.41 | 13.29 | |||||
EBITA, 5 Yr. CAGR % | 24.93 | 25.37 | 13.29 | 24.18 | 8.23 | |||||
EBIT, 5 Yr. CAGR % | 26.79 | 26.62 | 13.6 | 25.57 | 9.59 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 22.8 | 20.61 | 15.06 | 22.05 | 19.34 | |||||
Net Income, 5 Yr. CAGR % | 22.26 | 20.78 | 15.34 | 20.56 | 19.49 | |||||
Normalized Net Income, 5 Yr. CAGR % | 17.1 | 21.68 | 17.9 | 65.02 | 14.81 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 22.45 | 21.46 | 16.41 | 21.12 | 21.21 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.71 | 0.33 | 3.77 | 7.52 | 8.23 | |||||
Inventory, 5 Yr. CAGR % | 13.24 | 6.76 | 5.53 | 6.71 | 5.2 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -0.28 | 0.91 | 3.15 | 4.52 | 2.7 | |||||
Total Assets, 5 Yr. CAGR % | 3.66 | 2.95 | 5.56 | 7.8 | 8.71 | |||||
Tangible Book Value, 5 Yr. CAGR % | 6.98 | 11.76 | 13.99 | 21.04 | 20.18 | |||||
Common Equity, 5 Yr. CAGR % | 5.9 | 10.19 | 11.83 | 19.08 | 19.18 | |||||
Cash From Operations, 5 Yr. CAGR % | -0.77 | 19.06 | 9.2 | 12.83 | 6.16 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.92 | 0.21 | 10.47 | 10.07 | 4.34 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.27 | 53.04 | 7.13 | 12.84 | -1.43 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -3.71 | 43 | 5.04 | 12.35 | 2.28 | |||||
Dividend Per Share, 5 Yr. CAGR % | 21.94 | 20.27 | 20.11 | 22.1 | 26.64 |
- Stock Market
- Stocks
- 8002 Stock
- Financials Marubeni Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















